Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

  • You have access
    Preclinical Evaluation of 68Ga/177Lu labeled novel FAP-targeted peptide for tumor radionuclide imaging and therapy
    Weichen Wang, Rang Wang, MingXing Huang and Rong Tian
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242425;
  • You have access
    Investigating α- and β-emitting radionuclides targeting myeloid cells in a preclinical glioblastoma model.
    Ambika Parmar, Chaim Sneiderman, Sarah Vincze, ReidAnn Sever, Anders Josefsson, Jessie Nedrow and Gary Kohanbash
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242558;
  • You have access
    Evaluating and Extending the Applications of 18F-Fluciclovine Positron Emission Tomography in Boron Neutron Capture Therapy
    Ting-Yu Chang, Min-Tzu Ku, Wen-Yi Chang, Yi-Wei Chen, Nan-Jing Peng and Chun-Yi Wu
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242462;
  • You have access
    Preliminary evaluation of a 18F-labeled guanidine derivative in pheochromocytoma model
    YUE QI WANG and Wei Chen
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242511;
  • You have access
    Discovery of a highly speicific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging and radiotherapy of multiple myeloma
    Lu Wang, Jie Ma, Siqi Zhang and Kuan Hu
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242574;
  • You have access
    A Dimeric SV2A-Targeting Conjugate with Albumin Binding Towards Theranostic Application in Cancer with Neuroendocrine Differentiation
    Marian Awadalla, Sashi Debnath, Shelby Harris, Jer-Tsong Hsieh, Xiankai Sun and Guiyang Hao
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242399;
  • You have access
    Development of a novel TKI-PET probe targeting EGFR mutation
    Song Liu, Futao Liu and Zhi Yang
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242492;
  • You have access
    PD-L1 imaging and T cell imaging jointly achieve precise combination therapy of radiotherapy and immunotherapy
    Yi Hui, Qi Luo, Ma Xiaotu, Bai Zixian, Shi Jiyun and Fan Wang
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242520;
  • You have access
    Optimizing Fc-engineered novel anti-MSLN VH-Fc fusion proteins through PET imaging
    Abhinav Bhise, Xiaojie Chu, Anders Josefsson, Harikrishnan Rajkumar, Wei Li and Jessie Nedrow
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242602;
  • You have access
    PET Imaging of Tumor PD-L1 Expression with a 18F-labeled Bicyclic Peptide
    Xiaobo Wang, Zhiguo Liu, Weidong Yang, Fei Kang and Jing Wang
    Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 242427;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
SNMMI

© 2025 SNMMI

Powered by HighWire